Certified Advisory Corp Gilead Sciences, Inc. Transaction History

Certified Advisory Corp

$882 Million
Q3 2024

A detailed history of Certified Advisory Corp transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Certified Advisory Corp holds 10,477 shares of GILD stock, worth $944,920. This represents 0.1% of its overall portfolio holdings.

Number of Shares

10,477

Previous 10,699 2.07%

Holding current value

$944,920

Previous $734,000 19.62%

% of portfolio

0.1%

Previous 0.09%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$66.59 - $83.99 $14,782 - $18,645	-222 Reduced 2.07%	10,477 $878,000
Q2 2024 Aug 13, 2024	SELL	$63.15 - $72.88 $34,669 - $40,011	-549 Reduced 4.88%	10,699 $734,000
Q1 2024 May 10, 2024	SELL	$71.58 - $87.29 $9,591 - $11,696	-134 Reduced 1.18%	11,248 $823,000
Q4 2023 Feb 09, 2024	SELL	$73.27 - $83.09 $16,852 - $19,110	-230 Reduced 1.98%	11,382 $922,000
Q3 2023 Nov 13, 2023	SELL	$73.94 - $80.67 $43,846 - $47,837	-593 Reduced 4.86%	11,612 $870,000
Q2 2023 Aug 14, 2023	SELL	$76.01 - $86.7 $10,793 - $12,311	-142 Reduced 1.15%	12,205 $940,000
Q1 2023 May 15, 2023	BUY	$77.31 - $88.08 $695 - $792	9 Added 0.07%	12,347 $1.02 Million
Q4 2022 Feb 14, 2023	SELL	$62.32 - $89.47 $747 - $1,073	-12 Reduced 0.1%	12,338 $1.06 Million
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $107,588 - $122,894	-1,807 Reduced 12.76%	12,350 $761,000
Q2 2022 Aug 15, 2022	BUY	$57.72 - $65.01 $1,154 - $1,300	20 Added 0.14%	14,157 $875,000
Q1 2022 May 13, 2022	BUY	$57.92 - $72.58 $7,413 - $9,290	128 Added 0.91%	14,137 $840,000
Q4 2021 Feb 14, 2022	SELL	$64.88 - $73.64 $18,685 - $21,208	-288 Reduced 2.01%	14,009 $1.02 Million
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $10,898 - $11,757	161 Added 1.14%	14,297 $999,000
Q2 2021 Aug 16, 2021	SELL	$63.47 - $69.35 $10,980 - $11,997	-173 Reduced 1.21%	14,136 $974,000
Q1 2021 May 10, 2021	SELL	$60.0 - $68.46 $32,460 - $37,036	-541 Reduced 3.64%	14,309 $925,000
Q2 2020 Jul 27, 2020	BUY	$72.34 - $84.0 $9,042 - $10,500	125 Added 0.85%	14,850 $1.14 Million
Q1 2020 Apr 27, 2020	SELL	$62.63 - $80.22 $38,955 - $49,896	-622 Reduced 4.05%	14,725 $1.1 Million
Q4 2019 Jan 29, 2020	SELL	$61.62 - $67.78 $104,445 - $114,887	-1,695 Reduced 9.95%	15,347 $998,000
Q3 2019 Nov 12, 2019	SELL	$62.51 - $69.0 $138,272 - $152,628	-2,212 Reduced 11.49%	17,042 $1.08 Million
Q2 2019 Aug 07, 2019	SELL	$61.87 - $69.38 $4,763 - $5,342	-77 Reduced 0.4%	19,254 $1.3 Million
Q1 2019 May 07, 2019	SELL	$62.53 - $70.05 $8,754 - $9,807	-140 Reduced 0.72%	19,331 $1.26 Million
Q4 2018 Feb 04, 2019	SELL	$60.54 - $79.0 $109,819 - $143,306	-1,814 Reduced 8.52%	19,471 $1.22 Million
Q3 2018 Nov 13, 2018	BUY	$71.28 - $78.92 $1,425 - $1,578	20 Added 0.09%	21,285 $1.64 Million
Q2 2018 Aug 14, 2018	SELL	$64.88 - $75.68 $64,620 - $75,377	-996 Reduced 4.47%	21,265 $1.51 Million
Q1 2018 Apr 30, 2018	BUY	$72.84 - $88.8 $1.48 Million - $1.81 Million	20,382 Added 1084.73%	22,261 $1.68 Million
Q4 2017 Feb 22, 2018	BUY	$71.15 - $83.52 $133,690 - $156,934	1,879	1,879 $133,000

Others Institutions Holding GILD

# of Institutions

1,923

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Certified Advisory Corp, based on Form 13F filings with the SEC.

News

Stay updated on Certified Advisory Corp with notifications on news.

Account

Certified Advisory Corp Gilead Sciences, Inc. Transaction History